Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 6/16/2008 First Published: 4/23/2004


1.		Phase II Study of hu14.18-Interleukin-2 Fusion Protein in Children With Recurrent or Refractory Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				21 and under				NCI				COG-ANBL0322 ANBL0322, NCT00082758

Last Modified: 9/26/2007 First Published: 4/23/2005


2.		Phase II Study of Hu14.18-Interleukin-2 Fusion Protein in Patients With Advanced Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Temporarily closed				18 and over				NCI				WCCC-CO-04601 6304, NCI-6304, WCCC-H-2004-0396, NCT00109863


3.		Pilot hu14.18-IL2 and Cilengitide in Resectable Recurrent Stage III or Stage IV Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Temporarily closed				18 and over				NCI, Other				H2007-0087 CO05601, NCT00590824

Last Modified: 6/12/2007 First Published: 3/1/1999


4.		Phase I Study of hu14.18-Interleukin-2 Fusion Protein in Children With Refractory or Recurrent Neuroblastoma or Other GD2-Positive Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				21 and under				NCI				COG-ADVL0018 NCT00003750

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute